ID   PEPD_HUMAN              Reviewed;         493 AA.
AC   P12955; A8K3Z1; A8K416; A8K696; A8MX47; B4DDB7; B4DGJ1; E9PCE8;
AC   Q8TBN9; Q9BT75;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   22-JUL-2015, entry version 182.
DE   RecName: Full=Xaa-Pro dipeptidase;
DE            Short=X-Pro dipeptidase;
DE            EC=3.4.13.9;
DE   AltName: Full=Imidodipeptidase;
DE   AltName: Full=Peptidase D;
DE   AltName: Full=Proline dipeptidase;
DE            Short=Prolidase;
GN   Name=PEPD; Synonyms=PRD;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Liver, and Placenta;
RX   PubMed=2925654;
RA   Endo F., Tanoue A., Nakai H., Hata A., Indo Y., Titani K., Matsuda I.;
RT   "Primary structure and gene localization of human prolidase.";
RL   J. Biol. Chem. 264:4476-4481(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3), AND
RP   VARIANT PHE-435.
RC   TISSUE=Brain, and Kidney;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   PHE-435.
RC   TISSUE=Kidney, Skin, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   MASS SPECTROMETRY.
RC   TISSUE=Mammary cancer;
RX   PubMed=11840567;
RX   DOI=10.1002/1615-9861(200202)2:2<212::AID-PROT212>3.0.CO;2-H;
RA   Harris R.A., Yang A., Stein R.C., Lucy K., Brusten L., Herath A.,
RA   Parekh R., Waterfield M.D., O'Hare M.J., Neville M.A., Page M.J.,
RA   Zvelebil M.J.;
RT   "Cluster analysis of an extensive human breast cancer cell line
RT   protein expression map database.";
RL   Proteomics 2:212-223(2002).
RN   [7]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS], AND CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS], AND CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-167, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.82 ANGSTROMS) IN COMPLEX WITH MANGANESE IONS,
RP   AND COFACTOR.
RG   Protein structure factory (PSF);
RT   "Crystal structure of human prolidase: the molecular basis of PD
RT   disease.";
RL   Submitted (FEB-2009) to the PDB data bank.
RN   [12]
RP   VARIANT PD ASN-276.
RX   PubMed=2365824; DOI=10.1172/JCI114708;
RA   Tanoue A., Endo F., Kitano A., Matsuda I.;
RT   "A single nucleotide change in the prolidase gene in fibroblasts from
RT   two patients with polypeptide positive prolidase deficiency.
RT   Expression of the mutant enzyme in NIH 3T3 cells.";
RL   J. Clin. Invest. 86:351-355(1990).
RN   [13]
RP   VARIANTS PD ARG-448 AND GLU-452 DEL.
RX   PubMed=8198124;
RA   Ledoux P., Scriver C.R., Hechtman P.;
RT   "Four novel PEPD alleles causing prolidase deficiency.";
RL   Am. J. Hum. Genet. 54:1014-1021(1994).
RN   [14]
RP   VARIANTS PD GLN-184; ASP-278; ARG-448 AND GLU-452 DEL.
RX   PubMed=8900231;
RA   Ledoux P., Scriver C.R., Hechtman P.;
RT   "Expression and molecular analysis of mutations in prolidase
RT   deficiency.";
RL   Am. J. Hum. Genet. 59:1035-1039(1996).
RN   [15]
RP   VARIANT PD ARG-448.
RX   PubMed=12384772; DOI=10.1007/s00439-002-0792-5;
RA   Forlino A., Lupi A., Vaghi P., Icaro Cornaglia A., Calligaro A.,
RA   Campari E., Cetta G.;
RT   "Mutation analysis of five new patients affected by prolidase
RT   deficiency: the lack of enzyme activity causes necrosis-like cell
RT   death in cultured fibroblasts.";
RL   Hum. Genet. 111:314-322(2002).
CC   -!- FUNCTION: Splits dipeptides with a prolyl or hydroxyprolyl residue
CC       in the C-terminal position. Plays an important role in collagen
CC       metabolism because the high level of iminoacids in collagen.
CC   -!- CATALYTIC ACTIVITY: Hydrolysis of Xaa-|-Pro dipeptides; also acts
CC       on aminoacyl-hydroxyproline analogs. No action on Pro-|-Pro.
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|Ref.11};
CC       Note=Binds 2 manganese ions per subunit. {ECO:0000269|Ref.11};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|Ref.11}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P12955-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P12955-2; Sequence=VSP_042629;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=P12955-3; Sequence=VSP_045370;
CC         Note=No experimental confirmation available.;
CC   -!- MASS SPECTROMETRY: Mass=54251.73; Method=MALDI; Range=2-493;
CC       Evidence={ECO:0000269|PubMed:11840567};
CC   -!- DISEASE: Prolidase deficiency (PD) [MIM:170100]: A multisystem
CC       disorder associated with massive iminodipeptiduria and lack of or
CC       reduced prolidase activity in erythrocytes, leukocytes, or
CC       cultured fibroblasts. Clinical features include skin ulcers,
CC       developmental delay, recurrent infections, and a characteristic
CC       facies. {ECO:0000269|PubMed:12384772, ECO:0000269|PubMed:2365824,
CC       ECO:0000269|PubMed:8198124, ECO:0000269|PubMed:8900231}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the peptidase M24B family. Eukaryotic-type
CC       prolidase subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J04605; AAA60064.1; -; mRNA.
DR   EMBL; BT006692; AAP35338.1; -; mRNA.
DR   EMBL; AK290756; BAF83445.1; -; mRNA.
DR   EMBL; AK290781; BAF83470.1; -; mRNA.
DR   EMBL; AK291561; BAF84250.1; -; mRNA.
DR   EMBL; AK293126; BAG56678.1; -; mRNA.
DR   EMBL; AK294619; BAG57802.1; -; mRNA.
DR   EMBL; AC008744; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC010485; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC004305; AAH04305.1; -; mRNA.
DR   EMBL; BC015027; AAH15027.1; -; mRNA.
DR   EMBL; BC028295; AAH28295.1; -; mRNA.
DR   CCDS; CCDS42544.1; -. [P12955-1]
DR   CCDS; CCDS54244.1; -. [P12955-3]
DR   CCDS; CCDS54245.1; -. [P12955-2]
DR   PIR; A32454; A32454.
DR   RefSeq; NP_000276.2; NM_000285.3. [P12955-1]
DR   RefSeq; NP_001159528.1; NM_001166056.1. [P12955-2]
DR   RefSeq; NP_001159529.1; NM_001166057.1. [P12955-3]
DR   UniGene; Hs.36473; -.
DR   PDB; 2IW2; X-ray; 1.82 A; A/B=2-493.
DR   PDB; 2OKN; X-ray; 2.45 A; A/B=2-493.
DR   PDBsum; 2IW2; -.
DR   PDBsum; 2OKN; -.
DR   ProteinModelPortal; P12955; -.
DR   SMR; P12955; 6-482.
DR   BioGrid; 111208; 32.
DR   IntAct; P12955; 9.
DR   MINT; MINT-5000488; -.
DR   STRING; 9606.ENSP00000244137; -.
DR   BindingDB; P12955; -.
DR   ChEMBL; CHEMBL4185; -.
DR   MEROPS; M24.007; -.
DR   PhosphoSite; P12955; -.
DR   BioMuta; PEPD; -.
DR   DMDM; 50403718; -.
DR   REPRODUCTION-2DPAGE; IPI00257882; -.
DR   MaxQB; P12955; -.
DR   PaxDb; P12955; -.
DR   PeptideAtlas; P12955; -.
DR   PRIDE; P12955; -.
DR   DNASU; 5184; -.
DR   Ensembl; ENST00000244137; ENSP00000244137; ENSG00000124299.
DR   Ensembl; ENST00000397032; ENSP00000380226; ENSG00000124299. [P12955-2]
DR   Ensembl; ENST00000436370; ENSP00000391890; ENSG00000124299. [P12955-3]
DR   GeneID; 5184; -.
DR   KEGG; hsa:5184; -.
DR   UCSC; uc002nur.4; human. [P12955-1]
DR   UCSC; uc010xrr.2; human. [P12955-2]
DR   CTD; 5184; -.
DR   GeneCards; GC19M033877; -.
DR   HGNC; HGNC:8840; PEPD.
DR   HPA; HPA015599; -.
DR   MIM; 170100; phenotype.
DR   MIM; 613230; gene.
DR   neXtProt; NX_P12955; -.
DR   Orphanet; 742; Prolidase deficiency.
DR   PharmGKB; PA33181; -.
DR   eggNOG; COG0006; -.
DR   GeneTree; ENSGT00550000074992; -.
DR   HOGENOM; HOG000008763; -.
DR   HOVERGEN; HBG053562; -.
DR   InParanoid; P12955; -.
DR   KO; K14213; -.
DR   OMA; EPGCYGV; -.
DR   OrthoDB; EOG7FNC76; -.
DR   PhylomeDB; P12955; -.
DR   TreeFam; TF313396; -.
DR   BRENDA; 3.4.13.9; 2681.
DR   ChiTaRS; PEPD; human.
DR   EvolutionaryTrace; P12955; -.
DR   GeneWiki; PEPD; -.
DR   GenomeRNAi; 5184; -.
DR   NextBio; 20054; -.
DR   PRO; PR:P12955; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; P12955; -.
DR   CleanEx; HS_PEPD; -.
DR   ExpressionAtlas; P12955; baseline and differential.
DR   Genevisible; P12955; HS.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0004177; F:aminopeptidase activity; IEA:InterPro.
DR   GO; GO:0016805; F:dipeptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0030145; F:manganese ion binding; IEA:InterPro.
DR   GO; GO:0004181; F:metallocarboxypeptidase activity; TAS:ProtInc.
DR   GO; GO:0006520; P:cellular amino acid metabolic process; TAS:ProtInc.
DR   GO; GO:0030574; P:collagen catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006508; P:proteolysis; TAS:ProtInc.
DR   Gene3D; 3.40.350.10; -; 1.
DR   Gene3D; 3.90.230.10; -; 1.
DR   InterPro; IPR007865; Aminopep_P_N.
DR   InterPro; IPR029149; Creatin/AminoP/Spt16_NTD.
DR   InterPro; IPR028980; Creatinase/Aminopeptidase_P_N.
DR   InterPro; IPR000994; Pept_M24_structural-domain.
DR   InterPro; IPR001131; Peptidase_M24B_aminopep-P_CS.
DR   Pfam; PF05195; AMP_N; 1.
DR   Pfam; PF00557; Peptidase_M24; 1.
DR   SMART; SM01011; AMP_N; 1.
DR   SUPFAM; SSF53092; SSF53092; 1.
DR   SUPFAM; SSF55920; SSF55920; 1.
DR   PROSITE; PS00491; PROLINE_PEPTIDASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Collagen degradation;
KW   Complete proteome; Dipeptidase; Direct protein sequencing;
KW   Disease mutation; Hydrolase; Manganese; Metal-binding;
KW   Metalloprotease; Phosphoprotein; Polymorphism; Protease;
KW   Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:19413330,
FT                                ECO:0000269|PubMed:22223895}.
FT   CHAIN         2    493       Xaa-Pro dipeptidase.
FT                                /FTId=PRO_0000185087.
FT   METAL       276    276       Manganese 1.
FT   METAL       287    287       Manganese 1.
FT   METAL       287    287       Manganese 2.
FT   METAL       370    370       Manganese 2.
FT   METAL       412    412       Manganese 2.
FT   METAL       452    452       Manganese 1.
FT   METAL       452    452       Manganese 2.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000269|PubMed:19413330,
FT                                ECO:0000269|PubMed:22223895}.
FT   MOD_RES     167    167       Phosphoserine.
FT                                {ECO:0000269|PubMed:24275569}.
FT   VAR_SEQ      68    131       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045370.
FT   VAR_SEQ     184    224       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_042629.
FT   VARIANT     184    184       R -> Q (in PD).
FT                                {ECO:0000269|PubMed:8900231}.
FT                                /FTId=VAR_011614.
FT   VARIANT     276    276       D -> N (in PD).
FT                                {ECO:0000269|PubMed:2365824}.
FT                                /FTId=VAR_004404.
FT   VARIANT     278    278       G -> D (in PD).
FT                                {ECO:0000269|PubMed:8900231}.
FT                                /FTId=VAR_011615.
FT   VARIANT     388    388       R -> H (in dbSNP:rs2230062).
FT                                /FTId=VAR_051574.
FT   VARIANT     435    435       L -> F (in dbSNP:rs17570).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_014723.
FT   VARIANT     448    448       G -> R (in PD).
FT                                {ECO:0000269|PubMed:12384772,
FT                                ECO:0000269|PubMed:8198124,
FT                                ECO:0000269|PubMed:8900231}.
FT                                /FTId=VAR_004405.
FT   VARIANT     452    452       Missing (in PD).
FT                                {ECO:0000269|PubMed:8198124,
FT                                ECO:0000269|PubMed:8900231}.
FT                                /FTId=VAR_004406.
FT   CONFLICT     48     48       L -> R (in Ref. 3; BAF84250).
FT                                {ECO:0000305}.
FT   CONFLICT     66     66       R -> L (in Ref. 1; AAA60064).
FT                                {ECO:0000305}.
FT   CONFLICT    107    107       W -> R (in Ref. 3; BAF83470).
FT                                {ECO:0000305}.
FT   CONFLICT    108    108       M -> I (in Ref. 3; BAF83445).
FT                                {ECO:0000305}.
FT   CONFLICT    183    183       C -> S (in Ref. 1; AAA60064).
FT                                {ECO:0000305}.
FT   CONFLICT    221    221       E -> G (in Ref. 1; AAA60064).
FT                                {ECO:0000305}.
FT   CONFLICT    283    284       CF -> SV (in Ref. 1; AAA60064).
FT                                {ECO:0000305}.
FT   CONFLICT    294    294       A -> R (in Ref. 1; AAA60064).
FT                                {ECO:0000305}.
FT   CONFLICT    311    311       R -> L (in Ref. 1; AAA60064).
FT                                {ECO:0000305}.
FT   CONFLICT    324    324       V -> D (in Ref. 1; AAA60064).
FT                                {ECO:0000305}.
FT   CONFLICT    329    330       MH -> ID (in Ref. 1; AAA60064).
FT                                {ECO:0000305}.
FT   CONFLICT    408    408       V -> A (in Ref. 3; BAG56678).
FT                                {ECO:0000305}.
FT   CONFLICT    458    458       T -> I (in Ref. 1; AAA60064).
FT                                {ECO:0000305}.
FT   CONFLICT    478    478       C -> R (in Ref. 3; BAF83470).
FT                                {ECO:0000305}.
FT   HELIX        21     36       {ECO:0000244|PDB:2IW2}.
FT   STRAND       45     49       {ECO:0000244|PDB:2IW2}.
FT   STRAND       54     56       {ECO:0000244|PDB:2IW2}.
FT   HELIX        69     75       {ECO:0000244|PDB:2IW2}.
FT   STRAND       79     81       {ECO:0000244|PDB:2IW2}.
FT   STRAND       83     87       {ECO:0000244|PDB:2IW2}.
FT   TURN         88     90       {ECO:0000244|PDB:2IW2}.
FT   STRAND       93     97       {ECO:0000244|PDB:2IW2}.
FT   HELIX       102    104       {ECO:0000244|PDB:2IW2}.
FT   TURN        105    107       {ECO:0000244|PDB:2IW2}.
FT   HELIX       114    121       {ECO:0000244|PDB:2IW2}.
FT   STRAND      124    128       {ECO:0000244|PDB:2IW2}.
FT   HELIX       129    131       {ECO:0000244|PDB:2IW2}.
FT   HELIX       132    138       {ECO:0000244|PDB:2IW2}.
FT   TURN        152    154       {ECO:0000244|PDB:2IW2}.
FT   HELIX       166    168       {ECO:0000244|PDB:2IW2}.
FT   HELIX       176    185       {ECO:0000244|PDB:2IW2}.
FT   HELIX       189    212       {ECO:0000244|PDB:2IW2}.
FT   HELIX       219    234       {ECO:0000244|PDB:2IW2}.
FT   STRAND      238    241       {ECO:0000244|PDB:2IW2}.
FT   STRAND      244    247       {ECO:0000244|PDB:2IW2}.
FT   HELIX       248    252       {ECO:0000244|PDB:2IW2}.
FT   STRAND      272    277       {ECO:0000244|PDB:2IW2}.
FT   STRAND      279    281       {ECO:0000244|PDB:2IW2}.
FT   STRAND      288    293       {ECO:0000244|PDB:2IW2}.
FT   HELIX       300    319       {ECO:0000244|PDB:2IW2}.
FT   HELIX       326    343       {ECO:0000244|PDB:2IW2}.
FT   HELIX       351    356       {ECO:0000244|PDB:2IW2}.
FT   TURN        357    359       {ECO:0000244|PDB:2IW2}.
FT   HELIX       360    363       {ECO:0000244|PDB:2IW2}.
FT   STRAND      373    377       {ECO:0000244|PDB:2IW2}.
FT   HELIX       394    396       {ECO:0000244|PDB:2IW2}.
FT   STRAND      408    411       {ECO:0000244|PDB:2IW2}.
FT   STRAND      414    416       {ECO:0000244|PDB:2IW2}.
FT   HELIX       419    427       {ECO:0000244|PDB:2IW2}.
FT   HELIX       429    432       {ECO:0000244|PDB:2IW2}.
FT   HELIX       437    443       {ECO:0000244|PDB:2IW2}.
FT   STRAND      448    450       {ECO:0000244|PDB:2IW2}.
FT   STRAND      452    457       {ECO:0000244|PDB:2IW2}.
FT   STRAND      459    464       {ECO:0000244|PDB:2IW2}.
FT   HELIX       472    479       {ECO:0000244|PDB:2IW2}.
SQ   SEQUENCE   493 AA;  54548 MW;  E8C4A2497E44BA22 CRC64;
     MAAATGPSFW LGNETLKVPL ALFALNRQRL CERLRKNPAV QAGSIVVLQG GEETQRYCTD
     TGVLFRQESF FHWAFGVTEP GCYGVIDVDT GKSTLFVPRL PASHATWMGK IHSKEHFKEK
     YAVDDVQYVD EIASVLTSQK PSVLLTLRGV NTDSGSVCRE ASFDGISKFE VNNTILHPEI
     VECRVFKTDM ELEVLRYTNK ISSEAHREVM KAVKVGMKEY ELESLFEHYC YSRGGMRHSS
     YTCICGSGEN SAVLHYGHAG APNDRTIQNG DMCLFDMGGE YYCFASDITC SFPANGKFTA
     DQKAVYEAVL RSSRAVMGAM KPGVWWPDMH RLADRIHLEE LAHMGILSGS VDAMVQAHLG
     AVFMPHGLGH FLGIDVHDVG GYPEGVERID EPGLRSLRTA RHLQPGMVLT VEPGIYFIDH
     LLDEALADPA RASFLNREVL QRFRGFGGVR IEEDVVVTDS GIELLTCVPR TVEEIEACMA
     GCDKAFTPFS GPK
//
